We Care for Humanity
 
“Everything in the treatment and prevention of chronic diseases, which is not orthomolecular, will fail. “Dr Linus Pauling, Nobel Prize Winner, USA

In 1974, when the war on cancer was very young, Dr Linus Pauling, Nobel Prize winner, USA
made the following prophetic statement: 


Everything in the treatment and prevention of chronic diseases, which is not orthomolecular, will fail. 

Mechanisms of our body are unwilling in the medium term to react cooperatively to toximolecular substances.

Orthodox medicine will attempt to compensate for its disregard of this maxim – which is born out of narrow-mindedness and ignorance of the laws of nature- by spending vast sums of money, by commissioning research on a gigantic scale, and by propaganda. The attempt will fail, but it will cause a tremendous explosion in health costs, which will lead to serious social upheaval and economic and political crisis.

“Even industries which merge into vast conglomerates in order to be able to finance toximolecular, non-biological ‘medicines’ will fail.”

No amount of money in the world will ever make it possible to imitate the development of effective substances over hundreds of millions of years of biofunctional adaptation”

“Two to 4% of cancers respond to chemotherapy….The bottom line is for a few kinds of cancer chemo is a life extending procedure—Hodgkin’s disease, Acute Lymphocytic Leukemia (ALL), Testicular cancer, and Choriocarcinoma.”—Ralph Moss, Ph.D. 1995 Author of Questioning Chemotherapy.

“NCI now actually anticipates further increases, and not decreases, in cancer mortality rates, from 171/100,000 in 1984 to 175/100,000 by the year 2000!”–Samuel Epstein.

“A study of over 10,000 patients shows clearly that chemo’s supposedly strong track record with Hodgkin’s disease (lymphoma) is actually a lie. Patients who underwent chemo were 14 times more likely to develop leukemia and 6 times more likely to develop cancers of the bones, joints, and soft tissues than those patients who did not undergo chemotherapy (NCI Journal 87:10).”—John Diamond

Children who are successfully treated for Hodgkin’s disease are 18 times more likely later to develop secondary malignant tumours. Girls face a 35 per cent chance of developing breast cancer by the time they are 40—which is 75 times greater than the average. The risk of leukemia increased markedly four years after the ending of successful treatment, and reached a plateau after 14 years, but the risk of developing solid tumours remained high and approached 30 per cent at 30 years (New Eng J Med, March 21, 1996)

“Success of most chemotherapy is appalling…There is no scientific evidence for its ability to extend in any appreciable way the lives of patients suffering from the most common organic cancer…chemotherapy for malignancies too advanced for surgery which accounts for 80% of all cancers is a scientific wasteland.”—Dr Ulrich Abel. 1990

The New England Journal of Medicine Reports— War on Cancer Is a Failure: Despite $30 billion spent on research and treatments since 1970, cancer remains “undefeated,” with a death rate not lower but 6% higher in 1997 than 1970, stated John C. Bailar III, M.D., Ph.D., and Heather L. Gornik, M.H.S., both of the Department of Health Studies at the University of Chicago in Illinois. “The war against cancer is far from over,” stated Dr. Bailar. “The effect of new treatments for cancer on mortality has been largely disappointing.”

“My studies have proved conclusively that untreated cancer victims live up to four times longer than treated individuals. If one has cancer and opts to do nothing at all, he will live longer and feel better than if he undergoes radiation, chemotherapy or surgery, other than when used in immediate life-threatening situations.”—Prof Jones. (1956 Transactions of the N.Y. Academy of Medical Sciences, vol 6. There is a fifty page article by Hardin Jones of National Cancer Institute of Bethesda, Maryland. He surveyed global cancer of all types and compared the untreated and the treated, to conclude that the untreated outlives the treated, both in terms of quality and in terms of quantity. Secondly he said, “Cancer does not cure”. Third he said “There is a physiological mechanism which finishes off an individual”.)

“With some cancers, notably liver, lung, pancreas, bone and advanced breast, our 5 year survival from traditional therapy alone is virtually the same as it was 30 years ago.”—P Quillin, Ph.D.

“1.7% increase in terms of success rate a year, its nothing. By the time we get to the 24 century we might have effective treatments, Star Trek will be long gone by that time.” Ralph Moss.

“….chemotherapy’s success record is dismal. It can achieve remissions in about 7% of all human cancers; for an additional 15% of cases, survival can be “prolonged” beyond the point at which death would be expected without treatment. This type of survival is not the same as a cure or even restored quality of life.”—John Diamond, M.D.

“Keep in mind that the 5 year mark is still used as the official guideline for “cure” by mainstream oncologists. Statistically, the 5 year cure makes chemotherapy look good for certain kinds of cancer, but when you follow cancer patients beyond 5 years, the reality often shifts in a dramatic way.”—Diamond.

Studies show that women taking tamoxifen after surviving breast cancer then have a high propensity to develop endometrial cancer. The NCI and Zeneca Pharmaceuticals, which makes the drug, aggressively lobbied State of California regulators to keep them from adding tamoxifen to their list of carcinogens. Zeneca is one of the sponsors of Breast Cancer Awareness Month.

“Most cancer patients in this country die of chemotherapy…Chemotherapy does not eliminate breast, colon or lung cancers. This fact has been documented for over a decade. Yet doctors still use chemotherapy for these tumours…Women with breast cancer are likely to die faster with chemo than without it.”—Alan Levin, M.D.

According to the Cancer Statistics for 1995, published by the ACS in their small journal (2), the 5-year survival rate has improved from 50%-56% for whites and 39%-40% for blacks from 1974/1976 – 1983/1990. However, the data is taken from FIVE of the states with the lowest death rates AND the smallest populations! NONE of the 10 states with the highest death rates AND comprising 34% of the Total U.S. Cancer Deaths, were included in the data! Also, in prior years, the Composite (Ave.) 5-year survival rate for ALL Cancers Combined was computed and published. This Ave. 5-year survival crept upward to 50%, in the early nineties. It now stands around 51-52%, due primarily to the improvement of 11% survival for Colon and 13% increased survival for Prostate. It gets worse. The ACS boasts of “statistically significant” results when Uterine Ca survival drops from 89%/60%-85%/55% (W/B)?? Also, Pancreas Ca is 3-3 (W) and Laryngeal Ca survival drops from 59%-53% (B) while Cervical Ca drops from 63%-56% (B). Liver Ca improves from 4%-7%. I wonder how many Pancreatic and Hepatic Ca patients cheered these dramatic results? Ovarian Ca = 36%/40% – 42%/38% (W/B) and Breast Ca = 75%/63% – 82%/66% (W/B). In 16 years the Breast Ca rate improved 3-7%, while Uterine Ca decreased 4-5%. Aren’t these marvelous results that the Cancer Establishment should boast about??—RD Hodgell, M.D.

“The five year cancer survival statistics of the American Cancer Society are very misleading. They now count things that are not cancer, and, because we are able to diagnose at an earlier stage of the disease, patients falsely appear to live longer. Our whole cancer research in the past 20 years has been a failure. More people over 30 are dying from cancer than ever before…More women with mild or benign diseases are being included in statistics and reported as being “cured”. When government officials point to survival figures and say they are winning the war against cancer they are using those survival rates improperly.”—Dr J. Bailer, New England Journal of Medicine (Dr Bailer’s answer to questions put by Neal Barnard MD of the Physicians Committee For Responsible Medicine and published in PCRM Update, sept/oct 1990.

“I look upon cancer in the same way that I look upon heart disease, arthritis, high blood pressure, or even obesity, for that matter, in that by dramatically strengthening the body’s immune system through diet, nutritional supplements, and exercise, the body can rid itself of the cancer, just as it does in other degenerative diseases. Consequently, I wouldn’t have chemotherapy and radiation because I’m not interested in therapies that cripple the immune system, and, in my opinion, virtually ensure failure for the majority of cancer patients.”—Dr Julian Whitaker, M.D.

“Finding a cure for cancer is absolutely contraindicated by the profits of the cancer industry’s chemotherapy, radiation, and surgery cash trough.”—Dr Diamond, M.D.

“We have a multi-billion dollar industry that is killing people, right and left, just for financial gain. Their idea of research is to see whether two doses of this poison is better than three doses of that poison.”—Glen Warner, M.D. oncologist.

John Robbins:

   “Percentage of cancer patients whose lives are predictably saved by chemotherapy – 3%

   Conclusive evidence (majority of cancers) that chemotherapy has any positive influcence on survival or quality of life – none.

   Percentage of oncologists who said if they had cancer they would not participate in chemotherapy trials due to its    “ineffectiveness and its unacceptable toxicity” – 75%

   Percentage of people with cancer in the U.S. who receive chemotherapy – 75%.

   Company that accounts for nearly half of the chemotherapy sales in the world – Bristol-Meyers Squibb.

   Chairman of the board of Bristol-Meyers – Richard L. Gelb.

   Mr. Gelb’s other job: vice chairman, board of overseers, board of managers, Memorial Sloan-Kettering Cancer Center, World’s largest private cancer treatment and research center.

   Chairman, Memorial Sloan-Kettering’s board of overseers, board of managers – John S. Reed.

   Reed’s other job – director, Philip Morris (tobacco company).

   Director, Ivax, Inc., a prominent chemotherapy company – Samuel Broder.

   Broder’s other job (until 1995) – executive director, National Cancer Institute.”from Reclaiming Our Health: Exploding the Medical Myth and Embracing the Source of True Healing by John Robbins.

“If you can shrink the tumour 50% or more for 28 days you have got the FDA’s definition of an active drug. That is called a response rate, so you have a response..(but) when you look to see if there is any life prolongation from taking this treatment what you find is all kinds of hocus pocus and song and dance about the disease free survival, and this and that. In the end there is no proof that chemotherapy in the vast majority of cases actually extends life, and this is the GREAT LIE about chemotherapy, that somehow there is a correlation between shrinking a tumour and extending the life of the patient.”—Ralph Moss

“The majority of publications equate the effect of chemotherapy with (tumour) response, irrespective of survival. Many oncologists take it for granted that response to therapy prolongs survival, an opinion which is based on a fallacy and which is not supported by clinical studies. To date there is no clear evidence that the treated patients, as a whole, benefit from chemotherapy as to their quality of life.”—Abel.1990.

“For the majority of the cancers we examined, the actual improvements (in survival) have been small or have been overestimated by the published rates…It is difficult to find that there has been much progress…(For breast cancer), there is a slight improvement…(which) is considerably less than reported.”—General Accounting Office

“As a chemist trained to interpret data, it is incromprehensible to me that physicians can ignore the clear evidence that chemotherapy does much, much more harm than good.”—Alan Nixon, Ph.D., Past President, American Chemical Society.

“He said, “I’m giving cancer patients over here at this major cancer clinic drugs that are killing them, and I can’t stop it because they say the protocol’s what’s important.” And I say, “But the patient’s not doing well.” They say, “The protocol’s what’s important, not the patient.” And he said, “You can’t believe what goes on in the name of medicine and science in this country.” –Gary Null

The Politics of Cancer—Epstein

That in spite of over $20 billion expenditures since the “War against Cancer” was launched by President Nixon in 1971, there has been little if any significant improvement in treatment and survival rates for most common cancers, in spite of contrary misleading hype by the cancer establishment—the National Cancer Institute (NCI) and American Cancer Society (ACS).

That the cancer establishment remains myopically fixated on damage control _diagnosis and treatment _ and basic genetic research, with, not always benign, indifference to cancer prevention. Meanwhile, the incidence of cancer, including nonsmoking cancers, has escalated to epidemic proportions with lifetime cancer risks now approaching 50%.

That the NCI has a long track record of budgetary shell games in efforts to mislead Congress and the public with its claim that it allocates substantial resources to cancer prevention. Over the last year, the NCI has made a series of widely divergent claims, ranging from $480 million to $1 billion, for its prevention budget while realistic estimates are well under $100 million.

That the NCI allocates less than 1% of its budget to research on occupational cancer _ the most avoidable of all cancers _ which accounts for well over 10% of all adult cancer deaths, besides being a major cause of childhood cancer.

That cancer establishment policies, particularly those of the ACS, are strongly influenced by pervasive conflicts of interest with the cancer drug and other industries. As admitted by former NCI director Samuel Broder, the NCI has become “what amounts to a governmental pharmaceutical company.”

That the MD Anderson Comprehensive Cancer Center was sued in August, 1998 for making unsubstantiated claims that it cures “well over 50% of people with cancer.”

That the NCI, with enthusiastic support from the ACS _ the tail that wags the NCI dog _ has effectively blocked funding for research and clinical trials on promising non-toxic alternative cancer drugs for decades, in favor of highly toxic and largely ineffective patented drugs developed by the multibillion dollar global cancer drug industry. Additionally, the cancer establishment has systematically harassed the proponents of non-toxic alternative cancer drugs.

That, as reported in The Chronicle of Philanthropy, the ACS is “more interested in accumulating wealth than saving lives.” Furthermore, it is the only known “charity” that makes contributions to political parties.

That the NCI and ACS have embarked on unethical trials with two hormonal drugs, tamoxifen and Evista, in ill-conceived attempts to prevent breast cancer in healthy women while suppressing evidence that these drugs are known to cause liver and ovarian cancer, respectively, and in spite of the short-term lethal complications of tamoxifen. The establishment also proposes further chemoprevention trials this fall on tamoxifen, and also Evista, in spite of two published long-term European studies on the ineffectiveness of tamoxifen. This represents medical malpractice verging on the criminal.

That the ACS and NCI have failed to provide Congress and regulatory agencies with available scientific information on a wide range of unwitting exposures to avoidable carcinogens in air, water, the workplace, and consumer products _food, cosmetics and toiletries, and household products. As a result, corrective legislative and regulatory action have not been taken.

That the cancer establishment has also failed to provide the public, particularly African American and underprivileged ethnic groups with their disproportionately higher cancer incidence rates, with information on avoidable carcinogenic exposures, thus depriving them of their right-to-know and effectively preventing them from taking action to protect themselves _ a flagrant denial of environmental justice

 
The Role of Water in Cell Theory Interesting new research has confirmed the essential nature of energetic water [like Enercel] in systems of cellular function and physiology.1. Cell Mol Biol (Noisy-le-grand). 2001 Jul;47(5):959-70.

Information forgotten or overlooked: fundamental flaws in the conventional view of the living cell.Hazlewood CF

AbstractOld ideas often persist long after sound evidence dictates otherwise. I attempt to report one such case in the life sciences, by pointing out what are perceived to be fundamental flaws or questions in conventional wisdom. It is my experience that much evidence not in support of the well accepted membrane pump view of the living cell has been overlooked, forgotten or even ignored. In presenting this idea, the evolution of our knowledge from the establishment of cellular and protoplasmic theory to the emergence of solution theory is presented.

The universal hypothesis based on physical chemical principles is presented, followed by the advent of the membrane-situated energy-requiring pump. The experimental demonstration of an inadequate energy supply for the first pump is discussed, followed by a review of new evidence that calls to question the use of dilute solution theory in describing adequately cellular function. Finally, roles for cellular water are suggested to explain the cellular exclusion of sodium and to serve as a barometer for the healthy state. Within the context of a metaphor, I attempt to qualitatively embrace the physical findings. It is concluded that the mobility of water molecules may be considered to change with the progression of normal tissue to a state of disease. These changes in the mobility of water molecules are “fingerprinted” by changes in the molecular motion of the solids.

2. Biochim Biophys Acta. 2008 Dec;1778(12):2655-70. Epub 2008 Sep 12.

Structural and functional properties of hydration and confined water in membrane interfaces.Disalvo EA, Lairion F, Martini F, Tymczyszyn E, Frías M, Almaleck H, Gordillo GJ.

AbstractThe scope of the present review focuses on the interfacial properties of cell membranes that may establish a link between the membrane and the cytosolic components. We present evidences that the current view of the membrane as a barrier of permeability that contains an aqueous solution of macromolecules may be replaced by one in which the membrane plays a structural and functional role.

Although this idea has been previously suggested, the present is the first systematic work that puts into relevance the relation water-membrane in terms of thermodynamic and structural properties of the interphases that cannot be ignored in the understanding of cell function. To pursue this aim, we introduce a new definition of interphase, in which the water is organized in different levels on the surface with different binding energies. Altogether determines the surface free energy necessary for the structural response to changes in the surrounding media. The physical chemical properties of this region are interpreted in terms of hydration water and confined water, which explain the interaction with proteins and could affect the modulation of enzyme activity. Information provided by several methodologies indicates that the organization of the hydration states is not restricted to the membrane plane albeit to a region extending into the cytoplasm, in which polar head groups play a relevant role. In addition, dynamic properties studied by cyclic voltammetry allow one to deduce the energetics of the conformational changes of the lipid head group in relation to the head-head interactions due to the presence of carbonyls and phosphates at the interphase. These groups are, apparently, surrounded by more than one layer of water molecules: a tightly bound shell, that mostly contributes to the dipole potential, and a second one that may be displaced by proteins and osmotic stress.

Hydration water around carbonyl and phosphate groups may change by the presence of polyhydroxylated compounds or by changing the chemical groups esterified to the phosphates, mainly choline, ethanolamine or glycerol. Thus, surface membrane properties, such as the dipole potential and the surface pressure, are modulated by the water at the interphase region by changing the structure of the membrane components.

An understanding of the properties of the structural water located at the hydration sites and the functional water confined around the polar head groups modulated by the hydrocarbon chains is helpful to interpret and analyze the consequences of water loss at the membranes of dehydrated cells. In this regard, a correlation between the effects of water activity on cell growth and the lipid composition is discussed in terms of the recovery of the cell volume and their viability. Critical analyses of the properties of water at the interface of lipid membranes merging from these results and others from the literature suggest that the interface links the membrane with the aqueous soluble proteins in a functional unit in which the cell may be considered as a complex structure stabilized by water rather than a water solution of macromolecules surrounded by a semi permeable barrier.

3. Physiol Chem Phys Med NMR. 2007;39(2):111-234.

Nano-protoplasm: the ultimate unit of life.Ling G

AbstractAmong the most promising scientific achievements of the 19th century was the recognition that the laws governing the dead world also govern the world of the living and that life has a physical basis called protoplasm. Regrettably, the definition of protoplasm provided then was (inescapably) incorrect, offering a (legitimate) reason for rejecting the concept of protoplasm by an overwhelming majority of later investigators, teachers and other opinion-makers. Without a recognized physical basis, Life itself also faded into the limbo of the unexplainable.

However, eventually the needed relevant parts of physics and chemistry to give a more cogent definition of protoplasm became available. That then made possible the construction in the early 1960′s of a unifying theory of the living cell, named the association-induction (AI) hypothesis. Historically speaking, the AI Hypothesis is the heir to the general concept of protoplasm as the physical basis of life-incorrect as the initial definition of protoplasm was notwithstanding. In the AI Hypothesis (AIH) the true or ultimate physical basis of life is not what the advocates of the protoplasm once considered as the physical basis of life. What they saw and construed as the physical basis of life is a particular kind of macroscopic protoplasm. In the AI Hypothesis, the basic unit (or physical basis) of life is microscopic protoplasm or nano-protoplasm, of which all macroscopic protoplasm is made.

The AI Hypothesis also had no difficulty offering a new definition to what life is in terms of fundamental physical-chemical laws. Nano-protoplasm is defined by what it is and what it does. In greater detail, it is defined (i) by its chemical composition given in Equation 1 on p. 124; (ii) by the mutual spatial and energetic relationships among the components as illustrated diagrammatically in Figure 5 on p. 125; and (iii) by the ability of these components to exist as coherent assemblies in either one of two alternative states, the resting and active living (or dead) state as according to Equation 5 on p. 142. The review then describes the AIH-based electronic and molecular mechanisms for the coherent assemblage of the components, for the maintenance of the living states and for the auto-cooperative transitions between the resting and active (or dead) living state.

Having completed the theoretical section, the review goes on to describe the experimental testing of the theory carried out in the past forty-some years (and even in time before that by authors who knew nothing of the theory.) These experimental studies fall into two broad categories. In the first category, are the experiments performed on ultra-simple models of nano-protoplasm made up from pure chemicals as prescribed in Equation 1 on p. 124.

The results show that they indeed behave qualitatively like that illustrated in Figure 5 and quantitatively follow the dictates of Equation 5. In the second category of experimental testing, parallel studies were carried out on nano-protoplasm as part of living cells–in carrying out each one of the four classical functions of cell physiology: (1) solute and water distribution; (2) solute and water permeability; (3) cellular resting and action potentials; (4) cellular swelling and shrinkage. The results show that the nano-protoplasm in situ too qualitatively behave like that shown in Figure 5 and quantitatively follow the dictates of Equation 5. The review ends on a discussion section, examining how cogent do the experimental data accumulated thus far support to the AI version of the concept of nano-protoplasm as the most basic unit of life.

 
Complex Homeopathy:By Julian Kenyon

Complex homeopathy is the use of combinations of generally low potency homeopathics together with herbs and in some cases other preparations and extracts.

The Argument for Complex Homeopathy:Although using homeopathics in this way began towards the end of the life of Samuel Hahnemann, founder of homeopathy, it has never been accepted by the establishment of classical homeopathy. Classical homeopathy can have astonishingly good results if the remedy is correct. However, to put forward the argument for complex homeopathy, there are a number of situations in which classical homeopathy does not work, and in my experience these clinical situations include:

  • Where there is an excess of toxins in the body or, indeed, outside the body if the patient is working in a polluted environment;
  • Where long-term conventional drugs such as steroids or antidepressants have been used;
  • Where the patient is immunosuppressed, which means that the immune system is working at less than optimal level. The most common group of patients who are like this are those who suffer from chronic fatigue syndrome, of which ME is one example.
The numbers of patients suffering from these conditions has grown vastly since Hahnemann’s death, and therefore classical homeopathy is, it could be argued, becoming less applicable. One way to resolve this situation is to use homeopathic complexes.

It has been found that low potency homeopathics potentiate the action of herbal medicines and vice versa. Therefore the use of these complex preparations produces very effective medications. Essentially, complex homeopathics bring out the best from both worlds, that of herbal medicine and that of homeopathic medicine combined in one medicine.

History of DevelopmentComplexes originated in Europe, and 30 years ago a number of homeopathic manufacturing pharmacies were producing well over a thousand complexes for a whole range of practitioners. When legislation came in requiring the pharmacies to register these preparations, they decided to select only the popular ones to keep costs down. By implication this means that the preparations that worked best were retained. Therefore most pharmacies ended up producing between 100 and 200 well-tried complexes for a range of clinical situations. The most recent addition to the range of complexes has come from America and seems to be of high quality.

Organ preparations derived from animal sources are often added to those mixtures. These have the effect of targeting the medication at a particular organ, depending on which organ preparations are added. In clinical practice this is very effective, and the American complex homeopathics develop this potential to its fullest. The majority of complex homeopathics, however, does not have organ preparations in them and so are suitable for vegetarians.

Treatment with Complex HomeopathyA very efficient way of using complexes is to treat the patient using an organ-based approach as in traditional Chinese medicine, which sees the patient’s illness as being due to the malfunction of one or a number of organs. The cause of the organ dysfunction is often toxic, but can be emotional or spiritual in some cases, and in others a combination of all three.

Isolating the organs can be achieved by making electrical measurements over acupuncture points as in bio-energetic regulatory medicine (such as Vega-testing). Appropriate complexes are then chosen to treat these organs. As a rule, complexes which are directed at digestive organs, such as the liver, pancreas, stomach and colon, are taken just before a meal, and complex remedies which are directed at the non-digestive organs, such as the lungs, heart, kidneys, etc., are taken after a meal. The patient is advised to drink plenty of water while taking the remedies to detoxify the body.

Detoxification is a major part of complex homeopathy and the use of nosodes is integral to this. Nosodes are homeopathic dilutions of toxins. These toxins may come from the outside in the form of pesticides, hydrocarbons, conventional drugs, heavy metals etc., or can be generated inside the body, by bacteria, viruses and a whole range of internal pollutants.

Various complex nosodes contain a whole range of potencies of the same toxin; this is known as a potency accord. The argument is that if the body is presented with a whole range of potencies it picks out those which it actually requires at the time.

This seems to work very well from a clinical point of view. Nosodes have the effect of releasing the toxins from an intracellular position and causing them to be excreted into extracellular fluid, as shown in several studies1. Once the toxin is in an extracellular position it needs to be excreted. Complex remedies assist this, particularly the class of remedies called drainage remedies, which improve excretion from the body via the kidneys, the colon and the skin (through sweating). Drinking plenty of water and having a low-stress, non-toxic (organic) diet are essential to encourage detoxification.

Pastor Felke and Complex Homeopathy Video

HomotoxicosisThis process has been encapsulated in the theory known as homotoxicosis proposed by Dr. Hans Reckeweg, a German doctor who did most of his work during the 1930s. It has generated the whole clinical approach as described here involving complex homeopathics.

The theory of homotoxicosis assumes that illness is the end result between homotoxins (poisons) and the body’s natural defenses. The most important part of the body’s defenses lies in the immune system, which has two main methods of dealing with invasion by foreign material. Immunoglobulins, which are large protein molecules (known as antibodies), are manufactured by special white cells against specific foreign bodies (known as antigens). In cell-mediated immunity, specialized white cells engulf the foreign material (known as phagocytosis) and digest it.

A great deal is known about the immunoglobulin system but relatively little about cell-mediated immunity. Complex homeopathy makes use of combinations of herbal and homeopathic remedies which stimulate both immune system responses in order to facilitate the body’s immune competence. The autonomic nervous system (the part of the nervous system controlling unconscious internal body functions such as heart rate, muscle contractions etc.) has a major part to play in balancing the body’s natural defenses between activity (stimulated by the sympathetic division of the autonomic nervous system) and quiescence (encouraged by the parasympathetic division of the autonomic nervous system). Many of the natural therapies work through the autonomic nervous system and therefore can be expected to improve the body’s natural defenses.

The second line of the body’s defenses lies in its methods of getting rid of toxins via the three main routes of excretion: the colon, the kidneys and the skin. Methods of encouraging elimination via these routes using bowel stimulants, diuretics and diaphoretics (substances that increase sweating) are the cornerstone of naturopathic and herbal practice. The fundamental feature of complex homeopathic therapy embodies these principals by including herbal components to encourage elimination.

The third line of our natural defenses is the lymphatic system. This consists of a vast network of tiny capillaries which permeate all the connective tissues of the body. The lymphatics drain tissue fluid away together with toxins into large aggregates of lymphatic tissue known as lymph nodes. The toxins carried by the lymph are largely excreted into the intestinal lumen via the so-called Peyer’s patches, aggregates of lymphatic tissue situated just below the intestinal lining of the small intestine.

The lymph system acts like an internal connective tissue cleansing system. Anything which impedes its flow or overwhelm it with toxins will soon give rise to a local accumulation of toxins. Also a slight rise in pressure inside the small intestine may prejudice the fine balance which allows the lymphatics to discharge into the intestine via the Peyer’s patches. Many complex homeopathic medications contain effective lymphatic stimulants; this is one of the important mechanisms contributing to the effectiveness of this form of therapy. Habitual constipation can be a major problem as it predisposes to toxins remaining in the lymphatic system. We have a lot to learn from the Victorian obsession with bowels and unfortunately much modern medicine has lost sight of these simple facts.

The Natural History of Disease Due to ToxinsThe body is constantly striving toward homeostasis or balance. The different processes which we consider as disease are in effect ways for the organism to defend itself against toxins which are damaging to the human body (called homotoxins). Homotoxicology describes six distinct phases of disease grouped together as humoral (Phases 1-3), when the toxins are present in the extracellular fluid; and the cellular (Phases 4-6), when the toxins are deposited in the cells and cause increasing degeneration.

Phase 1            Excretion phase— the physiological elimination of toxins via the gastrointestinal tract, kidneys, lungs and skin

Phase 2            Reaction phase—pathologically augmented elimination, associated with symptoms such as fever, pain or inflammation

Phase 3            Deposition phase—deposits such as gout, obesity, edema, benign tumors, etc. are seen to help the body deal with the toxin load through storing them

Phase 4            Impregnation phase—toxins penetrate into the cells. Cell enzymes and structures are damaged, cell membrane functions are disturbed. This phase may remain latent and can later develop into a weak spot in the organism. Illnesses such as migraines, asthma, ulcers or toxic liver damage are manifestations of this phase

Phase 5            Degeneration phase—destruction of intracellular structures through toxins, leading to an accumulation of degenerative products. This can manifest illnesses such as tuberculosis, osteoarthritis, liver cirrhosis, nephrosis etc.

Phase 6            Neoplasm phase—the degeneration has led to uncontrolled growth of one particular cell cluster at the expense of all other cells and the organism, and cancer develops

After Phase 3, attempts by the body to excrete toxins have no effect as the most damaging toxins are locked away inside the cells. Complex homeopathic treatment attempts to reverse these six phases by using nosodes to make the toxins accessible again for the elimination process. Through the effects of the nosodes, toxins move from the intracellular fluid to the extracellular fluid. The organs of excretion are stimulated with complex remedies and can now perform the task of ridding the body of the toxins which threaten its integrity.

Lay Use of Complex HomeopathyLay people can choose a complex remedy according to their particular condition, such as a sore throat or chest infection. In addition there are books on traditional Chinese medicine which give simple explanations of the function of each organ, and by studying these, lay people can decide which organs are mainly involved in their case. The appropriate complexes to stimulate these organs can then be chosen. The most common organs involved are the liver, large intestine and lungs, more or less in that order. More complicated problems such as irritable bowel syndrome or asthma require a trained practitioner to decide what remedy the patient should take.

CautionsWhereas in Germany and France complex medicines are licensed, in the UK they are available over the counter. They are usually sold as food supplements without any medical claims made in their advertisements or packaging. Therefore, the market in complex homeopathics is largely unregulated, as it is in classical homeopathy.

This has to be taken seriously because complexes from India, Asia and South America may contain heavy metals such as mercury or lead which are toxic and tend to accumulate in the liver. Also there have been two deaths from liver failure due to the ingestion of complex mixtures although this is a very rare occurrence2. This must be set against the number of deaths from the use of allopathic medicines, such as non-steroidal anti-inflammatory drugs in the treatment of arthritis which runs into the thousands each year in the United Kingdom alone3.

Complex homeopathy has a potential for aggravating the condition, as do many complementary therapies. However, proving of a homeopathic complex, which can happen in classical homeopathy if a single remedy is continued longer than it is required, is very uncommon.

ResearchSeveral clinical trials have been done with complex homeopathic preparations showing them to be effective4. A randomized, placebo-controlled, double-blind trial demonstrated benefit in the prophylaxis of flu or the common cold. The onset of the symptoms was delayed in the test group and the severity of the symptoms was reduced5.

References:1.  JC Cazin; N Gaborit; JL Chaoui; J Boiron; P Belon; P Cherruault; C Papapanayotou. A study of the effect of decimal and centecimal dilutions of arsenic on the retention of mobilization of arsenic in the rat. Human Toxicology 1987;6:315-20

2.  P Fisher at al. The influence of the homeopathic remedy plumben metallicum on the excretion kinetics of lead in rats. Human Toxicology 1987;6:321-24

3.  Veterinary Human Toxicology 1995;37:562-66

4.  Vernon Coleman. The Betrayal of Trust. Europ. Med. J. 1994;4

5.  M Weiser; PPE Clausen. Controlled double blind study of a homeopathic sinusitis medication. Biological Therapy 1995;XIII(1):4-11

6.  A Heilmann. A combination injection preparation for flu and common colds. Biological Therapy 1994;XII(4):249-53

 Further ReadingClausen CF. Homotoxicology—the core of a probiotic and holistic approach to medicine.  Aurelia Verlag, 1988.

Kenyon JN. Modern techniques of acupuncture—a scientific guide to bio-electronic regulatory techniques and complex homeopathy. Vol 3, Thorsons, 1985.

Schimmel H. Guidelines for the treatment of chronic disease using complex homeopathy. Vol I, Pascoe Pharmaceutical Preparations, Giessen (Germany), 1984

Schmid F. Biological medicine—scientific position, medication and therapeutic techniques. Aurelia Verlag, 1991.

Reckeweg HH. Homotoxicology—illness and healing through anti-homotoxic therapy. Menaco Publishing Co., 1980

JournalBiological Therapy—Journal of Natural Medicine. Menaco Publishing Co., USA

Julian Kenyon   Modern Techniques of Acupuncture: A Scientific Guide to Bioelectronic Regulatory Techniques and Complex Homeopathy

Homeopathy and CancerThe Banerji Clinic in India has been successfully using homeopathic products for cancer. Their data has been successfully audited by the National Cancer Institute and has been published.

SEE LINK HERE:      http://bit.ly/11TGV2y

Homeopathy Overview [source: energymedicinereview.com]Homeopathy is a system of natural health care that has been in worldwide use for over 200 years. It is recognized by the World Health Organization as the second largest therapeutic system in use in the world. While it is most popular in India and South America, over thirty million people in Europe, and millions of others around the world, also benefit from its use.

The name homeopathy, coined by its originator, Samuel Hahnemann, is derived from the Greek words for ‘similar suffering’ referring to the ‘like cures like’ principle of healing. Hahnemann was born in Germany two hundred and fifty years ago. At this time the old world-view was being renovated and traditional beliefs, many flimsily based upon superstition, were being increasingly subjected to the rigour of experimental scrutiny and assessment. The practice of Homeopathy is based upon science while its application is an art.

Homeopathy is founded on two principles that have occurred regularly throughout the history of medicine, both in eastern and western worlds. The first principle of ‘like cures like’ can be looked at in several ways. One way is to assume that the body knows what it is doing and that symptoms are the body’s way of taking action to overcome illness. This healing response is automatic in living organisms; we term it the vital response. The similar medicine acts as a stimulus to the natural vital response, giving it the information it needs to complete its healing work. Since the initial action of the vital response plus the medicine is to increase the strength of the symptoms, this is our first indication of internal healing taking place, of diseases being cured from within – pushed outwards along the established routes of past and present symptoms.

Before the medicines are decided upon, their curative powers are discovered by testing them out on healthy human subjects and carefully noting emotional, mental and physical changes. This is termed a ‘proving’. This information constitutes the basis for ‘like cures like’, for a medicine’s unique symptom picture must match up with the individual’s unique expression of their disease, that is, the present and persisting symptoms of the disease.

The second principle, that only ‘the minimum dose’ should be employed is based upon the understanding that the stimulus of the medicine works from within the vitality and is not imposed from the outside. Only enough is administered to initiate the healing process, which then carries on, driven by its own internal healing mission. Homeopathic medicines given in minimum doses, while they do stimulate the body’s vital response, do not produce the gross side effects that are so often the pit-fall of conventional treatment.

Homeopathy is a gentle, holistic system of healing, suitable for everyone, young and old. Homeopathy focuses on you as an individual, concentrating on treating your specific physical and emotional symptoms, to give long lasting benefits.

Homeopathic remedies are a unique, potentised energy medicine, drawn from the plant, mineral and animal worlds. They are diluted to such a degree that not one molecule of the original substance can be detected (after the 12c potency).

They work by gently boosting the natural energy of the body, and are very safe, even for pregnant and sensitive patients. There is no danger of addiction or toxicity.

The clinical indications of homeopathic medicines are discovered in all of three ways:

    • The toxicity symptoms (or poisoning picture, eg. vomiting and diarrhoea caused by arsenic)

    • The ‘signature’ of the medicine, an ancient medical idea based on the ‘affinities’ of certain substances (eg. Deadly Nightshade, Atropa belladonna has large shiny black berries that resemble the dilated pupils of the eyes in high fever)

    • The ‘proving’, in which the highly diluted substances are tested blind on a group of healthy volunteers who then record the symptoms they experience. Where there is agreement amongst provers, the symptoms are documented in a Repertory.

All this information is used to match the remedies with the patients symptoms.

When visiting a homeopath they will understand that establishing good health involves treating both mind and body, so time is taken to listen to your emotional and physical symptoms. To stimulate your body’s own healing process, a remedy closest to your individual symptom picture is prescribed. Healing begins from within your body, strengthening your health and immune system, without any danger of damaging side effects.

Modern Computerized devices have now created treatments using homeopathic resonance and digital representations of the remedies.

Homeopathy is now being understood scientifically as Informational Medicine.

We recommend reading the book Decoding the Human Body-field – The New Science of Information as Medicine [available at amazon.com]

Decoding the Human Body-Field: The New Science of Information as Medicine

In this new book, Peter Fraser joins forces with Harry Massey and Joan Parisi Wilcox to present to you a system that unites the meridian system of traditional Chinese medicine with quantum wave theory to provide the first link between the human body’s biochemistry and bioenergetics.

Other recommendations:

Betrayal of Trust

Modern Techniques of Acupuncture: A Scientific Guide to Bioelectronic Regulatory Techniques and Complex Homeopathy

 
 Energy Medicine ResourcesI. Book review: The Encyclopedia of Energy Medicine

by Stanford Erickson

Editorial director, Chiropractic Economics and MASSAGE Magazine

Anyone who has studied physics understands that our bodies can be described and understood electromagnetically. The problem with many who went into healthcare — be it chiropractors, osteopaths, massage therapists, or medical doctors — is that often their education was so focused on biology and chemistry they did not have time to take courses in physics.

What is now called energy medicine, therefore, was often relegated by professional healthcare practitioners as unscientific New Age speculation.

But that is now undergoing change with chiropractors and massage therapists in the vanguard of those promoting the legitimacy of this understanding of how the body works electromagnetically and physicians, somewhat grudgingly, following along.

Linnie Thomas’s “The Encyclopedia of Energy Medicine” is a good 568-page primer in covering many of the approaches to harnessing and enhancing the body’s own energy to assist in healing.

 The book is available at booksellers, Amazon.com (Click the link above to go to Amazon), and from the publisher, Fairview Press, at fairviewpress.org.

James L. Oschman, PhD, former president of the International Society for the Study of Subtle Energies and Energy Medicine, sums up the benefit of this compendium when he states in the book’s forward:

“This book therefore serves a variety of important purposes. For the student looking for a rewarding career, this is the most comprehensive description of the opportunities available … for the researcher looking for new and fertile areas for investigation, there is no better compendium of techniques and concepts waiting to be explored. For patients wondering about alternative therapies, this is an excellent place to start their search.”

I would add that this is useful too for health practitioners because it provides morale support for those already practicing energy healing and, for those who are not, it might help wake them up to a whole new exciting world of healthcare.

II. A Review of Donna Eden’s Energy Medicine

By Kristine Clemenger

When it comes to having experience with and teaching about energy medicine, Donna Eden is the star. Donna communicates with a warmth and truth that are so sincere that it is easy to understand how she has become so popular and been able to share her teaching with so many people.

Energy Medicine is a valuable resource for anyone who wants to take control of their personal health and well being. If you are open to learning about energy and our ability to help strengthen and influence our own energies then this book has so much to offer. And if you are looking for a better understanding of this complex subject and how it can help you, I can not think of a better place to begin. The book is designed to help us boost our own stamina and immune system and stay healthy and balanced. It does this by teaching in easy to understand language and illustrations, simple routines and exercises designed to boost and balance your energy.

The book begins by giving an explanation of energy and energy medicine and how you can help your own body to achieve better natural health. Donna has a better understanding of energy than most of us ever will and explains that many of these techniques are not new but rather, as she has discovered them and studies them she notices similarities to practices that have been around for thousands of years across the globe. What is old is new again. She explains the nature of how energy works with, in and around us and how this influences our bodies. She also talks about the difference in how human technologies have changed the energy around us over time, how that may be affecting us and what we can do.

Later in the book, Donna gives a detailed explanation of energy testing and how to learn this valuable assessment skill. She then goes on to describe the various energy systems of the body such as the aura, the chakras, and the meridians and how they work in traditional acupuncture as well as in other energy techniques.

My favorite part of the book is the “daily energy routine”. This is a series of ‘exercises’ that are taught in the book which help keep your energies balanced and humming. I have been doing these along with a few others that I like from the book nearly every day for years. Adding this regimen to my day helps keep me healthy, energized, balanced and calm.

Energy Medicine : by Donna Eden [available at amazon.com]

III.             Book review – Energy Medicine for Women

Journalist and writer Rachel Newcombe reviews a long anticipated book, Energy Medicine for Women.

This hefty tome by Donna Eden, with Dr David Feinstein, is a much awaited follow-up to her bestselling book, Energy Medicine.

However, if you’re not familiar with her original book, there are certainly no disadvantages to be had by starting off by reading this one.

At the heart of Donna Eden’s theory is the idea that everyone can work with their own body’s energy systems to boost their natural healing ability.

Where her original book looked at energy medicine in general, Energy Medicine for Women focuses specifically on how the techniques can be used to help a range of women’s health problems.

The book contains seven chapters, first looking at what energy medicine is and the basic techniques involved, and then going on to explore how it can be used to help boost women’s health.

In particular, it looks at health and vitality, hormones, easing menstrual symptoms, sexuality, fertility, pregnancy and birth, the menopause and weight management.

Throughout the book there are a lot of do-it-yourself exercises to try out – great for putting ideas into practice and seeing how they actually work – and plenty of photographs to show exactly how to do things.

The photos are a big help, as they’re often marked to illustrate the position of acupressure points, which helps remove the worry that you’ve not got your hands in the right place!

As well as utilizing acupressure points and tapping, many of the techniques include simple movements too, such as the Cross Crawl, which ‘facilitates the crossover of energy between the brain’s right and left hemispheres,’ and Connecting Heaven and Earth, designed to help keep your energy flowing well.

In addition to the main text, the appendix explores what energy testing is and how to learn how to do it, plus there’s useful notes, including detailed references, and resources.

Anecdotal evidence

Donna includes lots of anecdotal material, which brings her work to life, and provides excellent examples of how beneficial energy medicine can be.

Her tale about how she went into the operating theatre with her daughter when she was having a fibroid removed, so that she could administer energy medicine was particularly striking.

Energy medicine and similar techniques are often regarded as ‘alternative’ and separate to conventional medicine, so it’s good to hear how they can be successfully used in tandem with each other – and with such positive results.

Overall, if you’ve intrigued by energy medicine, this is very interesting read. The design and layout of the book, with its easy to read sections, makes it ideal for dipping into, and there are numerous techniques and ideas to take away and try.

Other Books on Energy Medicine:
Energy Medicine: Balancing Your Body’s Energies for Optimal Health, Joy, and Vitality

Energy Medicine for Women: Aligning Your Body’s Energies to Boost Your Health and Vitality

The Little Book of Energy Medicine: The Essential Guide to Balancing Your Body’s Energies

The Energy Medicine Kit

The Energy Medicine Kit

Energy Medicine: Practical Applications and Scientific Proof

Energy Medicine, The Esential Techniques

Energy Healing for Dogs

 
Picture
ENERCEL® scientists participated at the conference to celebrate the

120th anniversary of the founding of the

Pasteur Institute
in Saint Petersburg, Russia  June 2008




ABSTRACT:

Alternative Cellular Energy (ACE) Based Therapy of Childhood Diarrhea
W. John Martin,1 Miguel Reyes Guzman,2 Rafael Chacon Fuentes,2 Carlos E. Mena,2 Emillio Penate2  and Rafael Ruiz Izaguirre,2


Institute of Progressive Medicine, Burbank CA USA1 and Benjamin Bloom National Children’s Hospital, El Salvador2

Background: Acute diarrhea is a major killer of children under 5 years of age in developing countries. It is commonly caused by bacteria but can also be caused by viruses, such as rotavirus. The infectious agents impair the cellular energy requiring normal functioning of the gastrointestinal tract leading to diarrhea. Cellular energy is derived through the oxidative metabolism of foods and also through a biophysical “alternative cellular energy” (ACE) pathway. The term enerceuticals™ refers to compounds and formulations that can deliver ACE to plants, animals and humans. ENERCEL® is such a formulation that has found widespread use in a number of illnesses attributable to impaired cellular energy. The present study evaluated the use of ENERCEL®as therapy for children in El Salvador presenting to a hospital emergency room with acute diarrhea.

Methods: Two 3 ml intramuscular injections of ENERCEL® were administered as an adjunct to routine care to a randomized grouping of children less than 5 years of age with acute diarrhea (n=58). The control patients (n=53) received routine care. The clinical progress of the two groups was assessed during a 24 hour hospitalization period and again at 48 hours after hospital discharge.

Findings: ENERCEL® treated children showed significantly improved clinical outcome compared to children who only receive routine care. A noticeable effect was observed at the 24 hour hospitalization time point and confirmed when the children were reexamined 48 hours after hospital discharge. At this time, there were fewer children in the ENERCEL® treated group than in the controls with persisting increased peristalsis(p<0.001), moderate dehydration (p=0.0224),, fever (p=0.0126) and continued multiple bowel movements (p=0.0035). Benefit occurred in both rotavirus antigen positive and rotavirus negative child ren with acute diarrhea.

Interpretation: ENERCEL® provides an effective adjunct to the routine care of young children with acute diarrhea in developing countries. ENERCEL® represents a class of broadly acting non-toxic enerceuticals™ that can seemingly enhance the body’s capacity to regain normal cellular function through the ACE pathway. Enerceuticals™ provide an attractive alternative to disease specific pharmaceuticals in the therapy of many illnesses of both infectious and non-infectious origin. 


 
ENERCEL® SUMMARY FOR HEALTH PROFESSIONALS

I.   PRECLINICAL SAFETY DATATOXICITYIn vitroEnercel® at a dose of 100 µl/mg was applied to confluent monolayers of both MOLT-5 and K562 cells. 5% ethanol was applied to control plates. Tissue culture media with fresh Enercel® at 100 µl/mg was added daily. The cells were observed for necrosis for 3 days. There was no toxicity (0 on a scale of 5).

AnimalsEither placebo (5% ethanol) or Enercel® at a dose of 0.35 cc SQ was administered to 10 mice per group for 28 consecutive days. The animals were observed clinically each day for toxicity. There was no ataxia, lethargy or respiratory distress. After 28 days, sections of harvested brains, kidneys, livers, pancreases and hearts were examined for inflammation and/or necrosis. None was found. A repeat study using the same parameters was performed.  Again, there was no clinical or microscopic toxicity.

Rats with experimentally-induced mammary gland tumors were treated with Enercel®, 0.05 to 1 ml IM/day. Control animals were given 1 ml placebo IM. No tissue necrosis was noted in biopsies from either group.

Mice were treated with 0.5 ml IM Enercel® daily for 30 days and evaluated for clinical and microscopic toxicity. There were no changes in color of the mucous membranes, hair, tail scaling, diarrhea, oral intake, movement, or posture. After sacrifice, internal organs were normal as to gross appearance, size, consistency, weight and blood vessels. Microscopic evaluation did not show any toxicity.

II.       RESULTS OF CLINICAL AND ANIMAL EFFICACY STUDIES OF ENERCEL®       A.   Immunomodulatory Effects of a Homeopathic Agent.

See DM, Tilles JG, Bertacchini C

Either 5% ethanol placebo or Enercel® was administered to groups of adolescent CD-1 mice at a dose of 0.35 cc SQ daily for 28 days.  None of the mice manifested any evidence of gross or microscopic toxicity (brains, kidneys, livers, pancreases, or hearts).  Splenic Natural Killer (NK) function versus YAC-1 targets was significantly greater in mice treated with the homeopathic agent Enercel® (mean 103 +/- 10.9 lytic units [LU]; p<.05) compared to placebo (mean 81 +/- 7.4 LU).  Groups of mice were treated with 21, 14, 7, or 0-day courses of Enercel® tincture or placebo.  They were then challenged with 1 x 104 plaque-forming units (PFU) of a diabetogenic strain of coxsackie virus B4 (E2).  Treatment was continued for an additional three days; then the mice were sacrificed.  Titers of virus in the pancreas were significantly reduced in the homeopathic group that was treated for 21 days prior to viral challenge (mean [log 10] 3.14 +/- 0.79 pfu/mg; p<.05) compared to placebo (mean [log 10] 4.29+/- 0.90 pfu/mg). Thus, a homeopathic medication, Enercel®, increased NK function both in vitro and in vivo and was non-toxic to mice.  In vivo antiviral activity was demonstrated, presumably through immune enhancement.

      B.    Effect of Enercel® on Acute Documented or Presumed Infectious Diarrhea in Children Less Than 5 Years of Age at the Emergency Ward of B. Bloom Hospital in San Salvador. 

Izaguirre RR, Guzmán, MR, Fuentes, RC, Mena CE, Peñate E.

AIMS: The homeopathic medicine Enercel® was tested in acute cases of presumed or documented infectious diarrhea in children less than 5 years of age. A total of 123 cases were evaluated– 59 in the control (observation) group and 64 in the test (Enercel®) group. Test subjects received 3 ml IM doses at baseline and 12 hours. Patients with parasitic and non-infectious causes of diarrhea were excluded. A clinical score to determine improvement or deterioration was created and applied to both groups. Statistical analysis was worked through EPI-INFO and SPSS programs. Clinical changes were measured every 6 hours for the first 24 hours, then again at 72 post-enrollment.

RESULTS: Both groups were comparable statistically in terms of clinical presentation, demographics and laboratory findings on enrollment. Differences in clinical status score became significant at 18 and 24 hours (p < 0.05) and more so at 72 hours after enrollment (p < 0.01). The Enercel®-treated group had significant improvement in fecal output at 12 – 18 hours and 18 – 24 hours (p < .01 for both). Seventeen subjects in the control and 15 in the test group had rotavirus infection. There was a borderline significant difference in clinical status at 18 hours (p = 0.08) and 24 hours (p = 0.06) after enrollment. At 72 hours, however, the difference was significant (p < 0.01).

CONCLUSIONS: Enercel® was effective in limiting clinical manifestations of infectious diarrhea in children < 5 years old. Such infections result in considerable morbidity and mortality in underdeveloped countries. The rotavirus infection subgroup responded more slowly, but the difference between control and test groups was significant at 72 hours. Enercel® may be a candidate as an inexpensive, completely safe alternative to antibiotic or symptom-only treatment of acute documented or presumed infectious diarrhea in children from developing nations.

C. Enercel®: A New Homeopathic Immune Enhancer Nasal Spray For Recurrent Allergic Disease Of The Upper Respiratory Tract: A Preliminary Communique. Izaguirre RR

A total of 30 cases, ages from 8 months to 82 years were enrolled. Each subject had the clinical diagnosis of recurrent allergic rhinitis, sinusitis and/or bronchitis. The protocol included a standard dose of two sprays of Enercel® Mist in each nostril three times per day in patients above five years of age; one spray three times per day in patients between two and five years of age; and one spray twice per day for infants under two years of age.  Clinical parameters followed were: sneezing, runny nose, nasal congestion, wheezing, hypertrophy of adenoidal tissues; infections and antibiotic use, cough, weight loss, fever, and frequency, duration and severity of relapses and the patient’s sense of well being. Subject response were graded from 1 to 4 on a clinical scale, with 1 being no response and 4 an excellent response. The use of Enercel® Mist Nasal spray favorably influenced allergic-originated upper respiratory tract recurrent disease with a score of 3 out of 4 (good) in 34.5% of the cases.  Excellent results (4/4) were recorded in an additional 58.6% of subjects for an overall positive response in 93.1%.  The clinical response was more pronounced  in patients below 30 years of age. No adverse reactions were reported in any case.

D. Can Wasted Muscle be Rehydrated and Functionally Enhanced?

     Hazlewood CF, Kereszti L.

In a pilot study, patients with atrophied muscles were injected with a Biological Response Modulator (Enercel®). The solution was injected into the motor points of the atrophied muscles. Within 24 – 48 hours, the volume of the treated muscles was increased.

E. Application Of Enercel® Mist, A Homeopathic Nasal Spray, In Cases Of Allergic Origin Otorhinological Diseases.

Kereszti GO

Eighty-two patients at an ENT outpatient clinic were sequentially enrolled into the study.  These subjects all had seasonal and perennial allergic rhinitis, confirmed with a prick test. The age of the patients ranged from 3 to 66 years. The number of patients under 14 years was 33 (39.3%), the number of adult patients were 49 (59.8%). Thirty-two percent (32%) of the patients had skin lesions and all patients had accompanying lower respiratory symptoms. One third of the patients were previously treated with other antiallergenic therapy. Enercel® Mist Nasal spray was delivered in 2 puffs, 4 times a day to both nostrils. Subjects were seen 1 week and 1 month after the initiation of treatment, at which time clinical examinations were done. They were also questioned about their symptoms and possible side effects. The symptoms of allergic rhinitis (congestion, itching, dripping, tearing, eye irritation) showed significant improvement (p <0.01) at 1 week and was maintained throughout the treatment. Some peripheral manifestations of allergies like atopic dermatitis and urticaria also improved. Obstructive airway symptoms (wheezing, coughing at rest and at exertion, shortness of breath) also improved significantly at 1 week on the symptomatic score index and it was maintained at one month.

F. Aspects of the Quality Of Life in Patients with Advanced Pancreatic Cancer. Bertacchini C. 

Eighty-seven patients with stage III or IV pancreatic cancer were enrolled in this trial. A questionnaire was devised to measure selective aspects of quality of life.  A survival curve was analyzed; and group follow-up was for twelve months. Daily doses of Enercel® 4 cc IM were administered during the entire study period. Sublingual and oral doses were also added for an additional 2.5 cc administered in four daily doses. A significant, beneficial effect was noted on several clinical parameters:  pain, appetite, nausea and vomiting, emotional state and physical function. Compared with historical controls with this stage and type of cancer, 1-year survival was significantly improved. Sixty subjects were still alive at 1 year.  The results of this study revealed that patients with advanced pancreatic cancer treated for 1 year with Enercel® had a significant improvement on selective aspects of quality of life and survival compared to historical controls.

G. Enercel® In Vivo Studies on Experimental Tumors.

Bergoc RM, Rivera ES

The efficacy of Enercel® in the treatment of induced mammary tumors in rats was evaluated. Escalating IM doses up to 1 ml/day for 10 days were assessed. After 10 days, the animals showed a clear improvement in their general wellness as manifested by greater mobility, friskiness and an increase in body weight as compared to placebo-treated controls. Tumor growth was arrested, and sometimes regressed, in a high proportion of lesions in the treated rats. Some tumors developed a characteristic central lesion consistent with tumor breakdown on histopathologic specimens. Statistical evaluation demonstrated that the survival of the test animals was significantly greater than that of the controls (p <0.01). The clinical and pathologic benefits of Enercel® were dose-dependent. There was no difference in end points between animals treated with low-dose (0.05 ml/day) Enercel® than in untreated controls. Thus, Enercel® treatment was beneficial in a rat model of induced mammary tumors in a dose-dependent fashion. All but the lowest dose was successful. Tumor regression, improved clinical signs and greater survival were observed in treated animals compared to no response in placebo-treated ones.

H. Significant Neurological Improvement in Two Patients with Amyotrophic Lateral Sclerosis after 4 Weeks of Treatment with Acupuncture Injection Point Therapy Using Enercel®.

S. Liang DOM, D. Christner MD [MA], PhD, S. Du Laux MD[MA], D. Ac,

D. Laurent MD

Amyotrophic Lateral Sclerosis (ALS) is a progressive, uniformly fatal, degenerative disorder of upper and motor neurons without any current effective treatment. We report on two case-studies of patients with ALS treated with 4 weeks of Acupuncture injection point therapy using Enercel®. Two patients with advanced ALS were given Enercel® Plus IM 0.25 to 0.5 cc at specific Acupuncture points 5 days per week for 4 weeks. Patient #1 presented with flaccid paralysis of all 4 extremities and impaired speech and swallowing. By week 4, she had significant improvement in motor strength of all 4 extremities, R > L, and improvements in speech and swallowing. She did not continue EnercelÒ Acupoint injections and had slow, progressive loss of neurological function during 3 months of follow-up. Patient #2 had significantly impaired speech and mild motor loss in both upper extremities and left leg. After 4 weeks, his voice had significantly improved to the point that his speech was understandable and his motor function had returned to normal. He continued EnercelÒ Acupoint injections during the 3-month follow-up and the clinical improvement was retained. Thus, two patients with ALS improved after 4 weeks of Enercel® Acupoint injection therapy. Follow-up data suggests that ongoing therapy may be necessary in order to maintain the positive effects. This preliminary data merits further study and confirmation.

I.      Phase III Study of Four Weeks Treatment with Enercel® for New-onset, Presumed Drug-sensitive and Ten Weeks Therapy for Confirmed, Treatment-Refractory, Multi-drug Resistant Pulmonary Tuberculosis at the Regional Antituberculosis Hospital in Chernigov, Ukraine.

Dubrov V, Dubrov T, Suhareva V, Christner D, Baiamonte J, Laurent D, Sanseverino S

OBJECTIVE: To determine if the complex homeopathic medicine Enercel® is efficacious in short-term treatment of new-onset, presumed drug-sensitive and confirmed multi-drug resistant [MDR-TB] pulmonary tuberculosis [TB].

MATERIALS AND METHODS: Seven new-onset, presumed drug-sensitive pulmonary TB and eight MDR-TB patients were enrolled. They each had baseline AFB-positive sputum smears. Drug-sensitive patients were treated with Enercel® by intravenous, aerosolized, sublingual and intranasal routes for 30 consecutive days. MDR-TB patients were treated for 10 consecutive weeks. Endpoints included Chest X ray, sputum AFB smears and Quality of Life [QOL] evaluation as assessed by cough, energy, mood, appetite, night sweats, weight and ease of breathing. Safety of Enercel® was evaluated by complete blood count and liver function testing.

RESULTS AND DISCUSSION: Seven of seven [100%] presumed drug-sensitive patients were sputum AFB smear negative after 30 days. The 7 patients also had significantly decreased infiltrates and cavitations by Chest X ray. QOL significantly improved in all 7 patients. Four of eight [50%] MDR-TB patients were AFB smear negative and 1 more [12%] had significantly less AFB-positive organisms after 10 weeks. Each of these 5 responders had significantly improved Chest X ray findings. QOL significantly improved in each of the 8 patients. There were no toxicity or side effects associated with Enercel® use.

CONCLUSIONS: Enercel® was highly effective in a short time [30 days] for new-onset, presumed drug-sensitive pulmonary TB and 10 weeks for confirmed MDR-TB patients. There were no adverse events associated with Enercel® administration. Enercel® may be useful in improving outcomes, limiting mortality, improving general health, and reducing length of treatment in these populations. Finally, long-term medical costs to public health systems may be significantly reduced.

III.            UNDESIRABLE EFFECTS

Enercel® has no known toxicity—therefore, no specific laboratory studies are required. Testing should reflect the disease state itself and not the application of Enercel®.

Enercel® has been used in a single dose up to 100 ml intravenously without side-effects. It has also been taken multiple times per day for many years without adverse effects. Any potential side-effects are related to the route of administration and not to Enercel® itself. Enercel® IV may result in bleeding, bruising, pain and risk of infection at the site of administration.

Once-hundred twenty-three children less than 5 years of age were enrolled in a placebo-controlled study of acute diarrhea disease. The test group received 3 ml IM of Enercel® twice daily for two total doses. No clinical signs of toxicity were noted.

A single-dose study of Enercel® –100 ml intravenously– was performed. No clinical or laboratory evidence of toxicity was noted.

Eighty-two patients were treated with Enercel® Mist Nasal spray 2 puffs three times/day for 1 month. No adverse reactions were noted.

IV.      PARTICULARS OF ADMINISTRATION

Duration of therapy

The duration of therapy of Enercel® products is variable, depending on specific conditions and response to treatment. Clinical response to Enercel®has been observed within 2-3 hrs. A study of acute diarrhea in children reported resolution of symptoms in the majority of recipients after just 2 IM doses 12 hrs apart. Patients with pancreatic cancer were treated for 1 year with Enercel® given by IM, sublingual and oral routes. For many chronic conditions, Enercel® has been used daily for years without side effects or toxicity. Up to 50 ml of Enercel® Plus IV has been given intravenously on a daily basis for prolonged periods of time in patients with more serious illnesses without adverse effects. It is recommended that, for severe disorders, Enercel® IV be given 10 consecutive days followed by 2 days of detoxification in cycles as determined by clinical status.

 

Rate of administration

Enercel®  Plus I.V.—qd to q12hrs

Special populations

Patients with kidney/liver insufficiency: There are no known adverse effects in patients with hepatic or renal disease. Enercel® has been extensively used in these populations without problems. No dosage interval changes are required.

Elderly patients

Although the pharmacokinetic disposition of Enercel® in the elderly is similar to those seen in younger adults, there is no targeted clinical trial data about the safety and effectiveness of Enercel® in this population. Subgroup analysis of elderly subjects in clinical trials reveals a  similar clinical response and lack of toxicity as in younger adults. Enercel® has been used in thousands of elderly patients in open-label use without side effects and with clinical efficacy. Enercel® can be used safely and efficaciously in the elderly population.

Children

The World Health Advanced Technology, Ltd. database contains hundreds of anecdotal reports of children receiving Enercel® without toxicity or side effects.  Children have used the medication chronically with no side-effects or developmental delays. These include children with severe illnesses such as pneumonia and copious diarrhea. A formal study of Enercel® at 3 ml IM every 12 hrs. for two doses in a Pediatric population failed to show any local or systemic toxicity. A study of Enercel® Mist Nasal in allergic upper respiratory disorders included a large number of children without side effects. The IV route has been used in children up to 2 ml/kg/day– again, no toxicity was noted. There are no known limitations on the use of Enercel® in infants and children.

Contraindications

Enercel® has been used safely and effectively in patients with chronic diseases including;  heart disease; renal insufficiency; liver disorders; immunodeficiencies; autoimmune conditions; cancer; nervous system diseases and chronic infections. There are no known contraindications for Enercel®.

V.       MECHANISM OF ACTION

Professor Luc Montagnier is a French virologist who co-discovered HIV and who won the Nobel Prize in 2008.  Dr. Montagnier has received many other significant awards, though his newest research, which may explain how and why homeopathic medicines maintain their biological activity in extreme dilution, may be his most significant to date.

In a recent paper, Prof Montagnier and his team report the results of a series of rigorous experiments investigating the electromagnetic (EM) properties of highly diluted biological samples. 

The abstract of this research in part asserts, “A novel property of DNA is described: the capacity of some bacterial DNA sequences to induce electromagnetic waves at high aqueous dilutions.  It appears to be a resonance phenomenon triggered by the ambient electromagnetic background of very low frequency waves.”

Although homeopathy is not mentioned anywhere in the article, the researchers used aqueous solutions that were agitated and serially diluted (the researchers note that the solutions were “strongly agitated” and that this step was “critical for the generation of signals”).  The researchers also note that they used a device made by French immunologist Jacques Benveniste (the famous physician/scientist who conducted studies testing homeopathic doses and whose work was initially published in Nature, and then, it was “debunked” in that same journal a month later). 

The researchers found that pathogenic bacteria and viruses show a distinct EM signature at dilutions ranging from 10-5 to 10-12 (corresponding to 5X to 12X) and that small DNA fragments (responsible for pathogenicity) were solely accountable for the EM signal.

The researchers also noted that one experiment found significant effects from dilutions as high as 10-18 (equivalent to 18X).  The EM signature changed with dilution levels but was unaffected by the initial concentration and remained even after the remaining DNA fragments were destroyed by chemical agents.  Of additional interest was the researchers’ observation that they observed the same results whether their initial concentration of cells were just 10 or 109.

They observed that the EM signal was destroyed by heating or freezing the sample (a common observation that homeopaths have also found in their medicines).  Also, a ‘cross-talk’ effect was found whereby a negative sample inhibits the positive signal in another sample if they are left together overnight in a shielded container. The researchers propose that specific aqueous nanostructures form in the samples during the dilution process and are responsible for the EM effects measured. 

The researchers also detected the same electromagnetic signals in the plasma and in the DNA extracted from the plasma of patients suffering from Alzheimer’s disease, Parkinson’s disease, multiple sclerosis, and rheumatoid arthritis.

The researchers also quote Italian physicist, E. Del Guidice, the same scientist whom Benveniste cited, for positing that water molecules can form long polymers of dipoles associated by hydrogen bonds and that electromagnetic radiations that they emit enable them to avoid decay. 

With this initial paper, Prof Montagnier and his team have started a very promising line of enquiry, which has direct relevance to homeopathy as they continue to investigate the characteristic physico-chemical properties found in high-dilutions of biological material. 

Reference:  Luc Montagnier, Jamal Aissa, Stéphane Ferris, Jean-Luc Montagnier, Claude Lavallee, Electromagnetic Signals Are Produced by Aqueous Nanostructures Derived from Bacterial DNA Sequences.  Interdiscip Sci Comput Life Sci (2009) 1: 81-90.

VI.      ENERPUNCTURE: THE COMBINATION OF ENERCEL® WITH ACUPUNCTURE

Enercel® and Acupuncture have been shown to be efficacious in a number of disorders due to stimulation and modulation of specific internal and external energy pathways.  Preliminary case-reports suggest that the combination may be synergistic in supporting organ, tissue and especially immune system function, presumably through energy modulation. This report primarily deals with the effect of Enercel® and Acupuncture—individually and in combination—on neurodegenerative disorders and neuropathies.

Energy Medicine is based upon the belief that changes in the “life force” of the body– including the electric, magnetic, and electromagnetic fields—can affect human health, and can be manipulated to promote healing.  Alternatively, a new concept of Energy Medicine embodies a network of under-differentiated, electromagnetically sensitive cells in the body that can be “triggered” by energetic substances to induce tissue repair and regeneration.

The notion of a life force or energy is shared by people around the world.  Since ancient times, traditional cultures have believed that a special energy vitalizes all life. This Energy has many other names. It is intriguing to consider that this ancient concept of Bio-Energy may now be in the process of scientific definition as stem cell-like, electromagnetically sensitive cells in the body capable of cellular reconstruction and restoration.

Over the course of the past three decades, Energy Medicine has moved from being a marginal area of research to gaining a large measure of mainstream acceptance.  Despite over 300 studies during the past 40 years showing the efficacy of energy healing, these findings are still ignored or rejected by many scientists based on non-reproducible and inconsistent results.  Distinct among modalities that improve and modulate energy in the body,  Enercel® has proven to have reliable, reproducible, consistently positive results in clinical, animal and in vitro studies.

ENERCEL® is a combination of homeopathics as per the Homeopathic Pharmacopoeia of the United States (HPUS).  Enercel® has been proven to be completely non-toxic and without negative side effects in patients both in clinical trials and general use. It is thought to work in the body by support of tissue and organ function via intra- and extracellular energy stimulation.

Enercel® activates the energy pathways of tissues throughout the body.  The energy enhancement in the tissues results in improved function, health, metabolism and resistance to infection and stress.  Once the energy of cells is normalized, particularly in the immune system, their health is restored and they are able to carry on their normal activities.  Furthermore, since all tissues in a local area are affected in this way, homeostasis, not just of cells but between cells as well, is restored.  When cells have sufficient and regulated energy, their function is modulated—when overactive, they quiet, and when underactive, they increase their activity.  Overall, Enercel® enhances the substrate of cells of the body in order to re-set them for optimal function. In particular, the immune system is effectively regulated. The turn-over of immune cells in areas of infection, inflammation, oxidation and/or necrosis is intense.  Homeostasis is difficult to achieve in such a milieu. Enercel® encourages self-modulation of immune function and the re-establishment of normal cellular, tissue and organ function. Symptoms of hypo- and hyperimmunity are reduced; infections are effectively fought; tissue damage is repaired; and pain and inflammation are diminished.

Enercel® has been successfully used in the management of neurodegenerative disorders.

Case report #1: A 40 year-old female suffered lower back trauma from a motor vehicle accident.  Subsequently she developed progressive weakness in her lower extremities, numbness in both feet, calf and feet muscle atrophy and a clumsy gait.  A spine MRI showed spinal stenosis.  She underwent back surgery to repair the stenosis—this resulted in a slower progression of lower extremity neurological symptoms but no regression.  She remained dependent on crutches.  Two years later, she began Enercel® by oral, IM and sublingual routes and by subcutaneous injection at specific Acupuncture points.  She showed slow improvement over a three-month period of daily administration of Enercel®.  At the end of that time, she was able to walk without crutches and had normal sensation in her feet.

Case report #2: A 70 year-old female developed right eye pain, swelling of the area around the eye and blisters on the forehead, which progressed over 3-4 days.  A diagnosis of ophthalmic herpes zoster was made.  She then began to suffer from right-side headaches, tingling, and pain over her eye consistent with post-herpetic neuralgia.  She began Enercel® Mist administration to her right eye every 2-3 hours as well as Enercel®intravenously (once daily) for 5 days.  The swelling and eye pain began to quickly improve and then resolved.  More significantly, her neurogenic headaches and supraorbital pain gradually diminished and then resolved over about 7 days.

ACUPUNCTURE is a technique of traditional Chinese medicine, in which a number of very fine metal needles are inserted into the skin at specially designated points.  For thousands of years acupuncture has been used, along with herbal medicine, for pain relief and treatment of various ailments. Today it is widely used in China in the treatment of hay fever, headaches, and ulcers, and some types of blindness, arthritis, diarrhea, and hypertension. Acupuncture is also used, especially in China, as a general anesthetic during childbirth and some types of surgery.

Generally, in the practice of acupuncture, needles varying in length from 1/2 in. (1.27 cm) to several inches are inserted in appropriate points of the body, not necessarily near the affected organ.  The needles are twirled and vibrated in specific ways; the depth of insertion also affects the treatment. Modern technique sometimes adds electrical stimulation applied through the needles. The traditional acupuncture points (about 800) are arranged along 14 lines, or meridians, running the length of the body from head to foot.

The traditional Chinese explanation of the effectiveness of acupuncture is based on the Taoist philosophy according to which good health depends on a free circulation of chi (qi), or life-force energy, throughout all the organs of the body.  The chi, in turn, depends upon a balance of the two opposing energies of yin (negative, dark, feminine) and yang (positive, bright, masculine). The meridians are the main channels of flow. When energy flow is impeded at any point, e.g., because of a diseased organ or stress, illness in other organs may result. Piercing the channels at the proper points is believed to correct the imbalances.

Western researchers have found that the acupuncture points correspond to points on the skin having less electrical resistance than other skin areas.  It has been suggested that acupuncture works by stimulating or repressing the autonomic nervous system in various ways, and there is some evidence that stimulation of the skin can affect internal organs by means of nerve reflex pathways. One theory is that acupuncture stimulates the release of natural pain-relieving chemicals called endorphins.  Another is that it stimulates the pituitary gland, which in turn stimulates the adrenal gland to release anti-inflammatory chemicals.

Since the early 1970s, acupuncture has gradually become more accepted in the United States.  Many states now accredit schools of acupuncture and administer licensing examinations for non-physicians. Some physicians are studying and using acupuncture as an adjunct treatment. In the United States acupuncture has been used most often for pain control and drug and alcohol addiction. One impediment to total acceptance is the difficulty of fitting a traditional technique from another culture into the strict methods of scientific clinical trials customary in Western medicine. However, a number of clinical trials have suggested that Acupuncture is efficacious for a number or disorders including neurodegenerative disorders and neuropathies.

Several studies have suggested that Acupuncture is beneficial in peripheral neuropathies.  One study of acupuncture in treating diabetic peripheral neuropathy involved 60 participants.  The study found that those receiving acupuncture had a statistically greater improvement in neurological symptoms as well as improved nerve function for both sensory and motor nerve conduction when compared to the control group.  Another study conducted in Africa found that for the 126 patients that received acupuncture for diabetic peripheral neuropathy, 86% deemed the treatment as being effective for reducing symptoms in their hands and feet.

In a 2006 Canadian study, acupuncture was utilized in five cases to reduce neuropathic pain in cancer patients.  The acupuncture treatment was deemed effective in these cases where medication had failed.  And finally, in a Chinese study involving 90 participants, those receiving total body or wrist and ankle acupuncture has significantly improved blood sugar and lipids, decreased blood viscosity, and improved functions of peripheral nerve cells, thus resulting in therapeutic effects for diabetic peripheral neuritis when compared to the control group.  The study also found no significant difference between the total body group and the ankle and wrist treatment group.

ENERCEL® TOGETHER WITH ACUPUNCTUREThe injection of liquid products into Acupuncture points—both drug and natural—labeled Acupuncture Injection Point Therapy (AIPT).  The treatment is based on the concept that products that enhance energy channels may work synergistically with Acupuncture.  Animal trials have validated the process in several models, including bee venom acupoint injections for adjuvant-induced arthritis.  Although few clinical trials are yet available, extensive experience in the community—especially in China—has yielded results beyond what may be achievable by Acupuncture or the drug/supplement in question alone.  This practice is a recognized procedure in several states (Florida, Arkansas, Colorado, New Mexico, and Washington).

The administration of Enercel® into Acupuncture points has been named Enerpuncture™.  This procedure has been of benefit for multiple patients with a variety of illnesses, most commonly musculoskeletal.  Clinical experience to date has suggested that Acupoint injection with Enercel® may improve outcomes for many disorders compared to Acupuncture alone.  Furthermore, Enerpuncture™ was successfully administered to multiple patients with a variety of neurodegenerative disorders and neuropathies.

VII.     CANCER AND ENERGY

Within the human body, each cell registers an electrical charge across the cell membrane.  Each cell’s interior carries a negative charge respective to the exterior charge.  This electrical charge is referred to as the transmembrane potential.  The magnitude of the transmembrane charge is different from cell to cell, ranging from about -50 to -70 millivolts.  In cells that are excitable (chargeable), it can be even less than -70 millivolts.  Cancer cells are proven to contain low amounts of energy, have a reduced transmembrane potential, and a low level of cellular energy production.

The transmembrane potential in cancer cells is about -15 millivolts, indicative of extremely low energy levels.  Such cells with low energy have a strong tendency to divide into two separate cells.  The reason for this is quite simple: as the intracellular energy drops to low levels, the existence of the cell is threatened and it is at risk for apoptosis or cell death.  The cell then begins to proliferate uncontrollably in an attempt to save itself.  As these low-energy, cancerous cells continue to rapidly proliferate, the amount of energy that is produced within the progeny cells is even further diminished.  As one could imagine, the new cells that are formed have even more reduced levels of energy than the initial cancer cells.

Cancer cells begin to form in an area of the body that is already low in energy levels.  Researchers found a connection between mitochondria and cancer back in the 1930′s.  What was discovered was that mitochondria become dysfunctional in cancer cells.  Based on research done at the University of Alberta, cancer growth can be hindered by facilitating the production of energy within the mitochondria.  Early theories stated that the mitochondria in cancer cells are permanently damaged and not treatable.  However, current research is now showing that damaged mitochondria can be restored, and when they are, there is a reduction in tumor growth.

These findings point to dysfunctional mitochondria—and a resultant low-energy state—as a direct causal factor in the growth of cancer.  These conclusions have been confirmed in both in vitro and animal studies.  Enercel® helps to restore normal mitochondrial energy production, raising the energy production of the cells and normalizing the transmembrane potential.  As normal energy production is restored in cancerous cells, they no longer feel threatened, and they do not proliferate uncontrollably in an attempt to ensure their survival.  In turn, this process may arrest the proliferation of cancerous cells.

VIII.    ENERCEL® AND STEM CELLS

Recent studies have suggested that a population of stem cells are electromagnetically sensitive.  That is, certain electromagnetic frequencies [EMF] stimulate the proliferation of stem cells.  Patents for the application of electric and/or electromagnetic frequencies to stem cells have been filed.  Furthermore, preliminary studies have suggested that Enercel® —a potent homeopathic biological electromagnetic energy inducer—can prolong the life-span and induce proliferation of peripheral blood mononuclear cells [PBMC] and mesenchymal stem cells [private communication, Christner].  The highly diluted biological components of Enercel® appear to activate in vivo and in vitro electromagnetic signals.




 

IX.        DISCLAIMER

Enercel® is a homeopathic formulation manufactured in strict conformity with the Homeopathic Pharmacopoeia of the United States (HPUS). Enercel® is not FDA approved for any medical condition and no claims are made that it can treat, cure, mitigate or prevent any illness.

 

 

 

 

Glossary
Molt 5  Cells that are more stable than   MOLT 4 cells;  are lymphoblast-like in morphology and are used for studies of apoptosis, tumor cytotoxicity, tumorigenicity, as well as for antitumour testing.

K562 (Human erythromyeloblastoid leukemia cell line) K-562 is an erythroleukemia cell line derived from a chronic myeloid leukemia patient in blast crisis. Recent studies have shown the K562 blasts are multipotential, hematopoietic malignant cells that spontaneously differentiate into recognisable progenitors of the erythrocyte, granulocyte and monocytic series. Cells are also used for haemoglobin synthesis, antitumour testing, tumorigenicity, differentiation, pharmacodynamics, cloning, cytotoxicity, cell biology, cellular effects of hyperthermia, and natural killer assays.

The CD-1 mouse is a multipurpose research animal model that can be used in such fields as toxicology (safety and efficacy testing), aging and oncology.

YAC-1 is a T cell lymphoma which was induced by inoculation of the Moloney leukemia virus (MLV) into a newborn A/Sn mouse.

Coxsackie B4 virus is a virus which can trigger an autoimmune reaction which results in destruction of the insulin-producing beta cells of the pancreas, which is one of several different etiologies of diabetes mellitus.

 

Epi Info is public domain statistical software for epidemiology developed by Centers for Disease Control and Prevention (CDC) in Atlanta, Georgia (USA).

SPSS  is among the most widely used programs for statistical analysis in social science.

otorhinology /oto·rhi·nol·o·gy/ (-ri-nol´ah-je) the branch of medicine dealing with the ear and nose. o·to·rhi·nol·o·gy ( t -r n l -j ). n.

AFB  acid-fast bacilli  Sputum smears or cultures.

QD or qd  means once daily.   Q12h or q12hrs means every twelve hours.

Enquiry:  a variant of inquiry.  A query is a single question; an inquiry (or enquiry) may be a single question or extensive investigation (i.e. a series of questions).

 
Potential Mechanism of Action of Homeopathic Formulations: Based on recent studies showing energetic activity of highly diluted biological compounds.Electromagnetic Signals Are Produced by Aqueous Nanostructures Derived from Bacterial DNA Sequences.

Professor Luc Montagnier is a French virologist who co-discovered HIV and who won the Nobel Prize in 2008.  Dr. Montagnier has received many other significant awards, though his newest research, which may explain how and why homeopathic medicines maintain their biological activity in extreme dilution, may be his most significant to date.

In a recent paper, Prof Montagnier and his team report the results of a series of rigorous experiments investigating the electromagnetic (EM) properties of highly-diluted biological samples. 

The abstract of this research in part asserts, “A novel property of DNA is described: the capacity of some bacterial DNA sequences to induce electromagnetic waves at high aqueous dilutions. It appears to be a resonance phenomenon triggered by the ambient electromagnetic background of very low frequency waves.”

Although homeopathy is not mentioned anywhere in the article, the researchers used aqueous solutions that were agitated and serially diluted (the researchers note that the solutions were “strongly agitated” and that this step was “critical for the generation of signals”).  The researchers also note that they used a device made by French immunologist Jacques Benveniste (the famous physician/scientist who conducted studies testing homeopathic doses and whose work was initially published in Nature, and then, it was “debunked” in that same journal a month later). 

The researchers found that pathogenic bacteria and viruses show a distinct EM signature at dilutions ranging from 10-5 to 10-12 (corresponding to 5X to 12X) and that small DNA fragments (responsible for pathogenicity) were solely accountable for the EM signal.

The researchers also noted that one experiment found significant effects from dilutions as high as 10-18 (equivalent to 18X).  The EM signature changed with dilution levels but was unaffected by the initial concentration and remained even after the remaining DNA fragments were destroyed by chemical agents.  Of additional interest was the researchers’ observation that they observed the same results whether their initial concentration of cells were just 10 or 109.

They observed that the EM signal was destroyed by heating or freezing the sample (a common observation that homeopaths have also found in their medicines). Also, a ‘cross-talk’ effect was found whereby a negative sample inhibits the positive signal in another sample if they are left together overnight in a shielded container. The researchers propose that specific aqueous nanostructures form in the samples during the dilution process and are responsible for the EM effects measured. 

The researchers also detected the same electromagnetic signals in the plasma and in the DNA extracted from the plasma of patients suffering from Alzheimer’s disease, Parkinson’s disease, multiple sclerosis, and rheumatoid arthritis.

The researchers also quote Italian physicist, E. Del Guidice, the same scientist who Benveniste cited, for positing that water molecules can form long polymers of dipoles associated by hydrogen bonds and that electromagnetic radiations that they emit enable them to avoid decay. 

With this initial paper Prof Montagnier and his team have started a very promising line of enquiry, which has direct relevance to homeopathy as they continue to investigate the characteristic physico-chemical properties found in high-dilutions of biological material. 

Reference:  Luc Montagnier, Jamal Aissa, Stéphane Ferris, Jean-Luc Montagnier, Claude Lavallee. Electromagnetic Signals Are Produced by Aqueous Nanostructures Derived from Bacterial DNA Sequences.  Interdiscip Sci Comput Life Sci (2009) 1: 81-90.

 

WCH and ENERCEL